These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 463773)

  • 61. [Present possibilities of the treatment of malignant ventricular arrhythmia in coronary disease].
    Breithardt G; Borggrefe M
    Dtsch Med Wochenschr; 1985 Dec; 110(51-52):1987-92. PubMed ID: 2416523
    [No Abstract]   [Full Text] [Related]  

  • 62. Efficacy of class Ib (lidocaine-like) antiarrhythmic agents for prevention of sustained ventricular tachycardia secondary to coronary artery disease.
    Reiter MJ; Easley AR; Mann DE
    Am J Cardiol; 1987 Jun; 59(15):1319-24. PubMed ID: 3109228
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Clinical and electrophysiologic findings in patients with repetitive monomorphic ventricular tachycardia and otherwise normal electrocardiogram.
    Rahilly GT; Prystowsky EN; Zipes DP; Naccarelli GV; Jackman WM; Heger JJ
    Am J Cardiol; 1982 Sep; 50(3):459-68. PubMed ID: 6810685
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Graded criteria to assess the effectiveness of anti-arrhythmia therapy in patients with ventricular tachyarrhythmia by serial electrophysiological testing].
    Borggrefe M; Breithardt G
    Z Kardiol; 1986 Feb; 75(2):70-9. PubMed ID: 3705680
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Transient entrainment and interruption of ventricular tachycardia.
    MacLean WA; Plumb VJ; Waldo AL
    Pacing Clin Electrophysiol; 1981 Jul; 4(4):358-66. PubMed ID: 6167952
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Clinical and induced ventricular tachycardia in a patient with myotonic dystrophy.
    Cannom DS; Wyman MG; Goldreyer BN
    J Am Coll Cardiol; 1984 Sep; 4(3):625-8. PubMed ID: 6470345
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Characteristics of ventricular tachycardia in ambulatory patients.
    Winkle RA; Derrington DC; Schroeder JS
    Am J Cardiol; 1977 Apr; 39(4):487-92. PubMed ID: 557893
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Nifekalant hydrochloride, a novel class III antiarrhythmic agent, suppressed postoperative recurrent ventricular tachycardia in a patient undergoing coronary artery bypass grafting and the Dor approach.
    Sahara M; Sagara K; Yamashita T; Iinuma H; Fu LT; Watanabe H
    Circ J; 2003 Aug; 67(8):712-4. PubMed ID: 12890916
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Prevention of recurrent life-threatening ventricular arrhythmias by temporary cardiac pacing.
    Pekarsky V; Gimrikh E; Karpov R; Popov S; Chekhov A; Savenkov G; Pekarskaya M
    Acta Med Scand; 1985; 217(1):95-9. PubMed ID: 3976438
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Adverse response to ventricular pacing but favorable response to atrial pacing in polymorphous ventricular tachycardia.
    Hill PE; Neill WA; Denes P
    Am Heart J; 1988 Nov; 116(5 Pt 1):1355-7. PubMed ID: 2461068
    [No Abstract]   [Full Text] [Related]  

  • 71. Delayed repolarization syndrome.
    Schweitzer P; Mark H
    Am J Med; 1983 Sep; 75(3):393-401. PubMed ID: 6614027
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Ventricular pacing in atypical ventricular tachycardia.
    Keren A; Tzivoni D; Golhman JM; Corcos P; Benhorin J; Stern S
    J Electrocardiol; 1981; 14(2):201-5. PubMed ID: 7276791
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Pacing termination of spontaneous ventricular tachycardia in the coronary care unit.
    Oldroyd KG; Rankin AC; Rae AP; Cobbe SM
    Int J Cardiol; 1992 Aug; 36(2):223-6. PubMed ID: 1512061
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Ventricular tachycardia and ventricular fibrillation in patients with short P-R intervals and narrow QRS complexes.
    Myerburg RJ; Sung RJ; Castellanos A
    Pacing Clin Electrophysiol; 1979 Nov; 2(6):568-78. PubMed ID: 95218
    [TBL] [Abstract][Full Text] [Related]  

  • 75. ELECTRICAL CONVERSION OF VENTRICUALAR TACHYCARDIA.
    DESANCTIS RW
    JAMA; 1965 Feb; 191():632-6. PubMed ID: 14242419
    [No Abstract]   [Full Text] [Related]  

  • 76. Management of recurrent ventricular tachyarrhythmias associated with Q-T prolongation.
    Khan MM; Logan KR; McComb JM; Adgey AA
    Am J Cardiol; 1981 Jun; 47(6):1301-8. PubMed ID: 6263071
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The management and outcome of late post-infarct ventricular tachycardia presenting to a district general hospital.
    Bourke SJ; Terry G; McComb JM; Bourke JP; Furniss SS; Campbell RW
    Int J Cardiol; 1992 Jun; 35(3):365-9. PubMed ID: 1612800
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Modification of ventricular tachycardia by procainamide in patients with coronary artery disease.
    Engel TR; Meister SG; Luck JC
    Am J Cardiol; 1980 Dec; 46(6):1033-8. PubMed ID: 7446417
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Ventricular tachycardia. Control by intermittent, intravenous administration of lidocaine hydrochloride.
    Bedynek JL; Weinstein KN; Kah RE; Minton PR
    JAMA; 1966 Oct; 198(5):553-5. PubMed ID: 5953279
    [No Abstract]   [Full Text] [Related]  

  • 80. Development of biventricular tachycardia in patient being medically treated for stable ventricular tachycardia.
    Barton ED; Podell RD
    J Emerg Med; 1995; 13(5):669-70. PubMed ID: 8530788
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.